Skip to main content Accessibility help
×
Home

Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study

  • H.-C. Kuo (a1) (a2), W.-C. Chang (a3), L.-J. Wang (a4), S.-C. Li (a5) and W.-P. Chang (a6)...

Abstract

Aims.

The association between Kawasaki disease (KD) and Attention deficit hyperactivity disorder (ADHD) has rarely been studied. In this study, we investigated the hypothesis that KD may increase the risk of ADHD using a nationwide Taiwanese population-based claims database.

Methods.

Our study cohort consisted of patients who were diagnosed with KD between January 1997 and December 2005 (N = 651). For a comparison cohort, five age- and gender-matched control patients for every patient in the study cohort were selected using random sampling (N = 3255). The cumulative incidence of ADHD was 3.89/1000 (from 0.05 to 0.85) in this study. All subjects were tracked for 5 years from the date of cohort entry to identify whether or not they had developed ADHD. Cox proportional hazard regression analysis was performed to evaluate 5-year ADHD-free survival rates.

Results.

Of all patients, 83 (2.1%) developed ADHD during the 5-year follow-up period, of whom 21 (3.2%) had KD and 62 (1.9%) were in the comparison cohort. The patients with KD seemed to be at an increased risk of developing ADHD (crude hazard ratio (HR): 1.71; 95% confidence interval (CI) = 1.04–2.80; p < 0.05). However, after adjusting for gender, age, asthma, allergic rhinitis, atopic dermatitis and meningitis, the adjusted hazard ratios (AHR) of the ADHD in patients with KD showed no association with the controls (AHR: 1.59; 95% CI = 0.96–2.62; p = 0.07). We also investigated whether or not KD was a gender-dependent risk factor for ADHD, and found that male patients with KD did not have an increased risk of ADHD (AHR: 1.62; 95% CI = 0.96–2.74; p = 0.07) compared with the female patients.

Conclusions.

The findings of this population-based study suggest that patients with KD may not have an increased risk of ADHD and whether or not there is an association between KD and ADHD remains uncertain.

Copyright

Corresponding author

*Address for correspondence: W.-P. Chang, Department of Healthcare Management, YuanPei University of Medical Technology, HsinChu, Taiwan. (Email: wpchang@mail.ypu.edu.tw)

References

Hide All
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC.
Arnsten, AF, Pliszka, SR (2011). Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacology Biochemistry and Behavior 99, 211216.
Bae, YJ, Kim, MH, Lee, HY, Uh, Y, Namgoong, MK, Cha, BH, Chun, JK (2012). Elevated serum levels of IL-21 in Kawasaki disease. Allergy, Asthma and Immunology Research 4, 351356.
Burns, JC, Glode, MP (2004). Kawasaki syndrome. Lancet 364, 533544.
Burns, JC, Shimizu, C, Shike, H, Newburger, JW, Sundel, RP, Baker, AL, Matsubara, T, Ishikawa, Y, Brophy, VA, Cheng, S, Grow, MA, Steiner, LL, Kono, N, Cantor, RM (2005). Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes and Immunity 6, 438444.
Buske-Kirschbaum, A, Schmitt, J, Plessow, F, Romanos, M, Weidinger, S, Roessner, V (2013). Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 38, 1223.
Chen, CY, Yeh, HH, Chen, KH, Chang, IS, Wu, EC, Lin, KM (2011). Differential effects of predictors on methylphenidate initiation and discontinuation among young people with newly diagnosed attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 21, 265273.
Chen, MH, Su, TP, Chen, YS, Hsu, JW, Huang, KL, Chang, WH, Chen, TJ, Bai, YM (2013). Comorbidity of allergic and autoimmune diseases among patients With ADHD: a nationwide population-based study. Journal of Attention Disorders. doi: 10.1177/1087054712474686.
Galera, C, Cote, SM, Bouvard, MP, Pingault, JB, Melchior, M, Michel, G, Boivin, M, Tremblay, RE (2011). Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years. Archives of General Psychiatry 68, 12671275.
Gau, SS, Chong, MY, Chen, TH, Cheng, AT (2005). A 3-year panel study of mental disorders among adolescents in Taiwan. American Journal of Psychiatry 162, 13441350.
Hak, E, de Vries, TW, Hoekstra, PJ, Jick, SS (2013). Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database. Annals of Allergy, Asthma and Immunology 111, 102106 e102.
Hikita, T, Kaminaga, T, Wakita, S, Ogita, K, Ikemoto, H, Fujii, Y, Oba, H, Yanagawa, Y (2011). Regional cerebral blood flow abnormalities in patients with Kawasaki disease. Clinical Nuclear Medicine 36, 643649.
Huang, WC, Huang, LM, Chang, IS, Chang, LY, Chiang, BL, Chen, PJ, Wu, MH, Lue, HC, Lee, CY (2009). Epidemiologic features of Kawasaki disease in Taiwan, 2003–2006. Pediatrics 123, e401e405.
Hwang, CY, Hwang, YY, Chen, YJ, Chen, CC, Lin, MW, Chen, TJ, Lee, DD, Chang, YT, Wang, WJ, Liu, HN (2013). Atopic diathesis in patients with kawasaki disease. The Journal of Pediatrics 163, 811815.
Kim, BN, Lee, JS, Shin, MS, Cho, SC, Lee, DS (2002). Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Statistical parametric mapping analysis. European Archives of Psychiatry and Clinical Neuroscience 252, 219225.
Kuo, HC, Yang, KD, Liang, CD, Bong, CN, Yu, HR, Wang, L, Wang, CL (2007). The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatric Allergy and Immunology 18, 354359.
Kuo, HC, Wang, CL, Liang, CD, Yu, HR, Huang, CF, Wang, L, Hwang, KP, Yang, KD (2009). Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatric Allergy and Immunology 20, 266272.
Kuo, HC, Yang, KD, Chang, WC, Ger, LP, Hsieh, KS (2012). Kawasaki disease: an update on diagnosis and treatment. Pediatrics and Neonatology 53, 411.
Kuo, HC, Chang, WC, Yang, KD, Yu, HR, Wang, CL, Ho, SC, Yang, CY (2013). Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study. BMC Pediatrics 13, 38.
Lee, CP, Huang, YH, Hsu, YW, Yang, KD, Chien, HC, Yu, HR, Yang, YL, Wang, CL, Chang, WC, Kuo, HC (2013). TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease. Pediatric Research 74, 545551.
Liang, CD, Kuo, HC, Yang, KD, Wang, CL, Ko, SF (2009). Coronary artery fistula associated with Kawasaki disease. American Heart Journal 157, 584588.
Millichap, JG (2008). Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics 121, e358e365.
Newburger, JW, Takahashi, M, Gerber, MA, Gewitz, MH, Tani, LY, Burns, JC, Shulman, ST, Bolger, AF, Ferrieri, P, Baltimore, RS, Wilson, WR, Baddour, LM, Levison, ME, Pallasch, TJ, Falace, DA, Taubert, KA (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110, 27472771.
Polanczyk, G, de Lima, MS, Horta, BL, Biederman, J, Rohde, LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 164, 942948.
Sagiv, SK, Epstein, JN, Bellinger, DC, Korrick, SA (2013). Pre- and postnatal risk factors for ADHD in a nonclinical pediatric population. Journal of Attention Disorders 17, 4757.
Schmitt, J, Buske-Kirschbaum, A, Roessner, V (2010). Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 65, 15061524.
Spencer, TJ, Biederman, J, Mick, E (2007). Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Journal of Pediatric Psychology 32, 631642.
Tsai, JD, Chang, SN, Mou, CH, Sung, FC, Lue, KH (2013 a). Association between atopic diseases and attention-deficit/hyperactivity disorder in childhood: a population-based case-control study. Annals of Epidemiology 23, 185188.
Tsai, YJ, Lin, CH, Fu, LS, Fu, YC, Lin, MC, Jan, SL (2013 b). The association between Kawasaki disease and allergic diseases, from infancy to school age. Allergy and Asthma Proceedings 34, 467472.
Wang, CL, Wu, YT, Liu, CA, Kuo, HC, Yang, KD (2005). Kawasaki disease: infection, immunity and genetics. The Pediatric Infectious Disease Journal 24, 9981004.
Wang, Y, Wang, W, Gong, F, Fu, S, Zhang, Q, Hu, J, Qi, Y, Xie, C, Zhang, Y (2013). Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis and Rheumatology 65, 805814.
Weng, KP, Ho, TY, Chiao, YH, Cheng, JT, Hsieh, KS, Huang, SH, Ou, SF, Liu, KH, Hsu, CJ, Lu, PJ, Hsiao, M, Ger, LP (2010). Cytokine genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children. Circulation Journal 74, 27262733.
Yaghmaie, P, Koudelka, CW, Simpson, EL (2013). Mental health comorbidity in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 131, 428433.

Keywords

Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study

  • H.-C. Kuo (a1) (a2), W.-C. Chang (a3), L.-J. Wang (a4), S.-C. Li (a5) and W.-P. Chang (a6)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed